Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Vaccines

  Free Subscription


Articles published in MMWR Morb Mortal Wkly Rep

Retrieve available abstracts of 171 articles:
HTML format



Single Articles


    July 2022
  1. FLEMING-DUTRA KE, Wallace M, Moulia DL, Twentyman E, et al
    Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months-5 Years - United States, June 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:859-868.
    PubMed     Abstract available


  2. DECUIR J, Meng L, Pan Y, Vogt T, et al
    COVID-19 Vaccine Provider Availability and Vaccination Coverage Among Children Aged 5-11 Years - United States, November 1, 2021-April 25, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:847-851.
    PubMed     Abstract available


    June 2022
  3. MALDEN DE, Hong V, Lewin BJ, Ackerson BK, et al
    Hospitalization and Emergency Department Encounters for COVID-19 After Paxlovid Treatment - California, December 2021-May 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:830-833.
    PubMed     Abstract available


  4. MARTIN J, Burns CC, Jorba J, Shulman LM, et al
    Genetic Characterization of Novel Oral Polio Vaccine Type 2 Viruses During Initial Use Phase Under Emergency Use Listing - Worldwide, March-October 2021.
    MMWR Morb Mortal Wkly Rep. 2022;71:786-790.
    PubMed     Abstract available


  5. KRISS JL, Hung MC, Srivastav A, Black CL, et al
    COVID-19 Vaccination Coverage, by Race and Ethnicity - National Immunization Survey Adult COVID Module, United States, December 2020-November 2021.
    MMWR Morb Mortal Wkly Rep. 2022;71:757-763.
    PubMed     Abstract available


  6. DAVLANTES E
    Notes from the Field: Initial Outbreak Response Activity Following Wild Poliovirus Type 1 Detection - Malawi, February 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:776-777.
    PubMed    


  7. RAO AK, Petersen BW, Whitehill F, Razeq JH, et al
    Use of JYNNEOS (Smallpox and Monkeypox Vaccine, Live, Nonreplicating) for Preexposure Vaccination of Persons at Risk for Occupational Exposure to Orthopoxviruses: Recommendations of the Advisory Committee on Immunization Practices - United States, 202
    MMWR Morb Mortal Wkly Rep. 2022;71:734-742.
    PubMed     Abstract available


    May 2022
  8. SAPKOTA S, Caruso E, Kobau R, Radhakrishnan L, et al
    Seizure- or Epilepsy-Related Emergency Department Visits Before and During the COVID-19 Pandemic - United States, 2019-2021.
    MMWR Morb Mortal Wkly Rep. 2022;71:703-708.
    PubMed     Abstract available


  9. WHITEHILL F, Bonaparte S, Hartloge C, Greenberg L, et al
    Rabies in a Dog Imported from Azerbaijan - Pennsylvania, 2021.
    MMWR Morb Mortal Wkly Rep. 2022;71:686-689.
    PubMed     Abstract available


  10. RACHLIN A, Patel JC, Burns CC, Jorba J, et al
    Progress Toward Polio Eradication - Worldwide, January 2020-April 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:650-655.
    PubMed     Abstract available


  11. RAO AK, Briggs D, Moore SM, Whitehill F, et al
    Use of a Modified Preexposure Prophylaxis Vaccination Schedule to Prevent Human Rabies: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:619-627.
    PubMed     Abstract available


  12. PRASAD N, Derado G, Nanduri SA, Reses HE, et al
    Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant - United States, February 14-March 27, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:633-637.
    PubMed     Abstract available


    April 2022
  13. SEITHER R, Laury J, Mugerwa-Kasujja A, Knighton CL, et al
    Vaccination Coverage with Selected Vaccines and Exemption Rates Among Children in Kindergarten - United States, 2020-21 School Year.
    MMWR Morb Mortal Wkly Rep. 2022;71:561-568.
    PubMed     Abstract available


  14. SHI DS, Whitaker M, Marks KJ, Anglin O, et al
    Hospitalizations of Children Aged 5-11 Years with Laboratory-Confirmed COVID-19 - COVID-NET, 14 States, March 2020-February 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:574-581.
    PubMed     Abstract available


  15. PLUMB ID, Feldstein LR, Barkley E, Posner AB, et al
    Effectiveness of COVID-19 mRNA Vaccination in Preventing COVID-19-Associated Hospitalization Among Adults with Previous SARS-CoV-2 Infection - United States, June 2021-February 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:549-555.
    PubMed     Abstract available


  16. SMITH DJ, Hakim AJ, Leung GM, Xu W, et al
    COVID-19 Mortality and Vaccine Coverage - Hong Kong Special Administrative Region, China, January 6, 2022-March 21, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:545-548.
    PubMed     Abstract available


  17. WILKINSON AL, Diop OM, Jorba J, Gardner T, et al
    Surveillance to Track Progress Toward Polio Eradication - Worldwide, 2020-2021.
    MMWR Morb Mortal Wkly Rep. 2022;71:538-544.
    PubMed     Abstract available


  18. BLOCK JP, Boehmer TK, Forrest CB, Carton TW, et al
    Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination - PCORnet, United States, January 2021-January 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:517-523.
    PubMed     Abstract available


  19. NATARAJAN K, Prasad N, Dascomb K, Irving SA, et al
    Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults - VIS
    MMWR Morb Mortal Wkly Rep. 2022;71:495-502.
    PubMed     Abstract available


  20. WENG MK, Doshani M, Khan MA, Frey S, et al
    Universal Hepatitis B Vaccination in Adults Aged 19-59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:477-483.
    PubMed     Abstract available


    March 2022
  21. TAYLOR CA, Whitaker M, Anglin O, Milucky J, et al
    COVID-19-Associated Hospitalizations Among Adults During SARS-CoV-2 Delta and Omicron Variant Predominance, by Race/Ethnicity and Vaccination Status - COVID-NET, 14 States, July 2021-January 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:466-473.
    PubMed     Abstract available


  22. TENFORDE MW, Self WH, Gaglani M, Ginde AA, et al
    Effectiveness of mRNA Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death - United States, March 2021-January 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:459-465.
    PubMed     Abstract available


  23. WALLACE M, Moulia D, Blain AE, Ricketts EK, et al
    The Advisory Committee on Immunization Practices' Recommendation for Use of Moderna COVID-19 Vaccine in Adults Aged >/=18 Years and Considerations for Extended Intervals for Administration of Primary Series Doses of mRNA COVID-19 Vaccines - United Sta
    MMWR Morb Mortal Wkly Rep. 2022;71:416-421.
    PubMed     Abstract available


  24. FOWLKES AL, Yoon SK, Lutrick K, Gwynn L, et al
    Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5-11 Years and Adolescents Aged 12-15 Years - PROTECT Cohort, July 2021-February 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:422-428.
    PubMed     Abstract available


  25. CHUNG JR, Kim SS, Kondor RJ, Smith C, et al
    Interim Estimates of 2021-22 Seasonal Influenza Vaccine Effectiveness - United States, February 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:365-370.
    PubMed     Abstract available


  26. KIM C, Yee R, Bhatkoti R, Carranza D, et al
    COVID-19 Vaccine Provider Access and Vaccination Coverage Among Children Aged 5-11 Years - United States, November 2021-January 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:378-383.
    PubMed     Abstract available


  27. O'CONNOR P, Huseynov S, Nielsen CF, Saidzoda F, et al
    Notes from the Field: Readiness for Use of Type 2 Novel Oral Poliovirus Vaccine in Response to a Type 2 Circulating Vaccine-Derived Poliovirus Outbreak - Tajikistan, 2020-2021.
    MMWR Morb Mortal Wkly Rep. 2022;71:361-362.
    PubMed    


  28. HAUSE AM, Baggs J, Marquez P, Abara WE, et al
    Safety Monitoring of COVID-19 Vaccine Booster Doses Among Persons Aged 12-17 Years - United States, December 9, 2021-February 20, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:347-351.
    PubMed     Abstract available


  29. SAELEE R, Zell E, Murthy BP, Castro-Roman P, et al
    Disparities in COVID-19 Vaccination Coverage Between Urban and Rural Counties - United States, December 14, 2020-January 31, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:335-340.
    PubMed     Abstract available


  30. KLEIN NP, Stockwell MS, Demarco M, Gaglani M, et al
    Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5-17 Years - VISION Net
    MMWR Morb Mortal Wkly Rep. 2022;71:352-358.
    PubMed     Abstract available


    February 2022
  31. MACK CD, Wasserman EB, Killerby ME, Soelaeman RH, et al
    Results from a Test-to-Release from Isolation Strategy Among Fully Vaccinated National Football League Players and Staff Members with COVID-19 - United States, December 14-19, 2021.
    MMWR Morb Mortal Wkly Rep. 2022;71:299-305.
    PubMed     Abstract available


  32. MALENFANT JH, Joyce A, Choi MJ, Cossaboom CM, et al
    Use of Ebola Vaccine: Expansion of Recommendations of the Advisory Committee on Immunization Practices To Include Two Additional Populations - United States, 2021.
    MMWR Morb Mortal Wkly Rep. 2022;71:290-292.
    PubMed     Abstract available


  33. HAUSE AM, Baggs J, Marquez P, Myers TR, et al
    Safety Monitoring of COVID-19 Vaccine Booster Doses Among Adults - United States, September 22, 2021-February 6, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:249-254.
    PubMed     Abstract available


  34. FERDINANDS JM, Rao S, Dixon BE, Mitchell PK, et al
    Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States,
    MMWR Morb Mortal Wkly Rep. 2022;71:255-263.
    PubMed     Abstract available


  35. SERVIES TE, Larsen EC, Lindsay RC, Jones JS, et al
    Notes from the Field: Outbreak of COVID-19 Among a Highly Vaccinated Population Aboard a U.S. Navy Ship After a Port Visit - Reykjavik, Iceland, July 2021.
    MMWR Morb Mortal Wkly Rep. 2022;71:279-281.
    PubMed    


  36. HALASA NB, Olson SM, Staat MA, Newhams MM, et al
    Effectiveness of Maternal Vaccination with mRNA COVID-19 Vaccine During Pregnancy Against COVID-19-Associated Hospitalization in Infants Aged <6 Months - 17 States, July 2021-January 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:264-270.
    PubMed     Abstract available


  37. SMITH-JEFFCOAT SE, Pomeroy MA, Sleweon S, Sami S, et al
    Multistate Outbreak of SARS-CoV-2 B.1.1.529 (Omicron) Variant Infections Among Persons in a Social Network Attending a Convention - New York City, November 18-December 20, 2021.
    MMWR Morb Mortal Wkly Rep. 2022;71:238-242.
    PubMed     Abstract available


  38. ZIMMERMAN LA, Knapp JK, Antoni S, Grant GB, et al
    Progress Toward Rubella and Congenital Rubella Syndrome Control and Elimination - Worldwide, 2012-2020.
    MMWR Morb Mortal Wkly Rep. 2022;71:196-201.
    PubMed     Abstract available


  39. DANZA P, Koo TH, Haddix M, Fisher R, et al
    SARS-CoV-2 Infection and Hospitalization Among Adults Aged >/=18 Years, by Vaccination Status, Before and During SARS-CoV-2 B.1.1.529 (Omicron) Variant Predominance - Los Angeles County, California, November 7, 2021-January 8, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:177-181.
    PubMed     Abstract available


  40. MCNAGHTEN AD, Brewer NT, Hung MC, Lu PJ, et al
    COVID-19 Vaccination Coverage and Vaccine Confidence by Sexual Orientation and Gender Identity - United States, August 29-October 30, 2021.
    MMWR Morb Mortal Wkly Rep. 2022;71:171-176.
    PubMed     Abstract available


  41. TESORIERO JM, Patterson W, Daskalakis D, Chicoine J, et al
    Notes from the Field: COVID-19 Vaccination Among Persons Living with Diagnosed HIV Infection - New York, October 2021.
    MMWR Morb Mortal Wkly Rep. 2022;71:182-184.
    PubMed    


    January 2022
  42. KOBAYASHI M, Farrar JL, Gierke R, Britton A, et al
    Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:109-117.
    PubMed     Abstract available


  43. JOHNSON AG, Amin AB, Ali AR, Hoots B, et al
    COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence - 25 U.S. Jurisdictions, April 4-December 25, 2021.
    MMWR Morb Mortal Wkly Rep. 2022;71:132-138.
    PubMed     Abstract available


  44. LEON TM, Dorabawila V, Nelson L, Lutterloh E, et al
    COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis - California and New York, May-November 2021.
    MMWR Morb Mortal Wkly Rep. 2022;71:125-131.
    PubMed     Abstract available


  45. TENFORDE MW, Patel MM, Gaglani M, Ginde AA, et al
    Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults - United States, August-December 2021.
    MMWR Morb Mortal Wkly Rep. 2022;71:118-124.
    PubMed     Abstract available


  46. OLIVER SE, Wallace M, See I, Mbaeyi S, et al
    Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices - United States, December 2021.
    MMWR Morb Mortal Wkly Rep. 2022;71:90-95.
    PubMed     Abstract available


  47. ANDERSON TC, Masters NB, Guo A, Shepersky L, et al
    Use of Recombinant Zoster Vaccine in Immunocompromised Adults Aged >/=19 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:80-84.
    PubMed     Abstract available


  48. THOMPSON MG, Natarajan K, Irving SA, Rowley EA, et al
    Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2
    MMWR Morb Mortal Wkly Rep. 2022;71:139-145.
    PubMed     Abstract available


  49. SADIGH KS, Akbar IE, Wadood MZ, Shukla H, et al
    Progress Toward Poliomyelitis Eradication - Afghanistan, January 2020-November 2021.
    MMWR Morb Mortal Wkly Rep. 2022;71:85-89.
    PubMed     Abstract available


  50. ZAMBRANO LD, Newhams MM, Olson SM, Halasa NB, et al
    Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12-18 Years - United States, July-December 2021.
    MMWR Morb Mortal Wkly Rep. 2022;71:52-58.
    PubMed     Abstract available


  51. LIPKIND HS, Vazquez-Benitez G, DeSilva M, Vesco KK, et al
    Receipt of COVID-19 Vaccine During Pregnancy and Preterm or Small-for-Gestational-Age at Birth - Eight Integrated Health Care Organizations, United States, December 15, 2020-July 22, 2021.
    MMWR Morb Mortal Wkly Rep. 2022;71:26-30.
    PubMed     Abstract available


  52. YEK C, Warner S, Wiltz JL, Sun J, et al
    Risk Factors for Severe COVID-19 Outcomes Among Persons Aged >/=18 Years Who Completed a Primary COVID-19 Vaccination Series - 465 Health Care Facilities, United States, December 2020-October 2021.
    MMWR Morb Mortal Wkly Rep. 2022;71:19-25.
    PubMed     Abstract available


    December 2021
  53. LUTRICK K, Rivers P, Yoo YM, Grant L, et al
    Interim Estimate of Vaccine Effectiveness of BNT162b2 (Pfizer-BioNTech) Vaccine in Preventing SARS-CoV-2 Infection Among Adolescents Aged 12-17 Years - Arizona, July-December 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1761-1765.
    PubMed     Abstract available



  54. QuickStats: Percentage* of Children and Adolescents Aged 1-17 Years Who Received an Influenza Vaccine Within the Past 12 Months,(dagger) by Health Insurance Coverage( section sign) and Age Group - National Health Interview Survey, United States, 2019-
    MMWR Morb Mortal Wkly Rep. 2021;70:1785.
    PubMed    


  55. HAUSE AM, Baggs J, Marquez P, Myers TR, et al
    COVID-19 Vaccine Safety in Children Aged 5-11 Years - United States, November 3-December 19, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1755-1760.
    PubMed     Abstract available


  56. WANGA V, Gerdes ME, Shi DS, Choudhary R, et al
    Characteristics and Clinical Outcomes of Children and Adolescents Aged <18 Years Hospitalized with COVID-19 - Six Hospitals, United States, July-August 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1766-1772.
    PubMed     Abstract available


  57. FAST HE, Zell E, Murthy BP, Murthy N, et al
    Booster and Additional Primary Dose COVID-19 Vaccinations Among Adults Aged >/=65 Years - United States, August 13, 2021-November 19, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1735-1739.
    PubMed     Abstract available


  58. NGUYEN KH, Yankey D, Lu PJ, Kriss JL, et al
    Report of Health Care Provider Recommendation for COVID-19 Vaccination Among Adults, by Recipient COVID-19 Vaccination Status and Attitudes - United States, April-September 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1723-1730.
    PubMed     Abstract available


  59. BAJEMA KL, Dahl RM, Evener SL, Prill MM, et al
    Comparative Effectiveness and Antibody Responses to Moderna and Pfizer-BioNTech COVID-19 Vaccines among Hospitalized Veterans - Five Veterans Affairs Medical Centers, United States, February 1-September 30, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1700-1705.
    PubMed     Abstract available


  60. ALLEMAN MM, Jorba J, Henderson E, Diop OM, et al
    Update on Vaccine-Derived Poliovirus Outbreaks - Worldwide, January 2020-June 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1691-1699.
    PubMed     Abstract available


  61. MONTGOMERY MP, Meehan AA, Cooper A, Toews KA, et al
    Notes from the Field: COVID-19 Vaccination Coverage Among Persons Experiencing Homelessness - Six U.S. Jurisdictions, December 2020-August 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1676-1678.
    PubMed    


    November 2021
  62. SHAH MM, Perez A, Lively JY, Avadhanula V, et al
    Enterovirus D68-Associated Acute Respiratory Illness horizontal line New Vaccine Surveillance Network, United States, July-November 2018-2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:1623-1628.
    PubMed     Abstract available


  63. KASEHAGEN L, Byers P, Taylor K, Kittle T, et al
    COVID-19-Associated Deaths After SARS-CoV-2 Infection During Pregnancy - Mississippi, March 1, 2020-October 6, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1646-1648.
    PubMed     Abstract available


  64. NALEWAY AL, Groom HC, Crawford PM, Salas SB, et al
    Incidence of SARS-CoV-2 Infection, Emergency Department Visits, and Hospitalizations Because of COVID-19 Among Persons Aged >/=12 Years, by COVID-19 Vaccination Status - Oregon and Washington, July 4-September 25, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1608-1612.
    PubMed     Abstract available


  65. WOODWORTH KR, Moulia D, Collins JP, Hadler SC, et al
    The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5-11 Years - United States, November 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1579-1583.
    PubMed     Abstract available



  66. QuickStats: Percentage* of Adults Aged >/=18 Years Who Received an Influenza Vaccination in the Past 12 Months,(dagger) by Sex and Age Group - National Health Interview Survey,( section sign) United States, 2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:1586.
    PubMed    


  67. ROMAN PC, Kirtland K, Zell ER, Jones-Jack N, et al
    Influenza Vaccinations During the COVID-19 Pandemic - 11 U.S. Jurisdictions, September-December 2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:1575-1578.
    PubMed     Abstract available


  68. DIXON MG, Ferrari M, Antoni S, Li X, et al
    Progress Toward Regional Measles Elimination - Worldwide, 2000-2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:1563-1569.
    PubMed     Abstract available


  69. EMBI PJ, Levy ME, Naleway AL, Patel P, et al
    Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults - Nine States, January-September 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1553-1559.
    PubMed     Abstract available


  70. BOZIO CH, Grannis SJ, Naleway AL, Ong TC, et al
    Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19-Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity - Nine States, January-September 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1539-1544.
    PubMed     Abstract available


  71. MBAEYI S, Oliver SE, Collins JP, Godfrey M, et al
    The Advisory Committee on Immunization Practices' Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines - United States, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1545-1552.
    PubMed     Abstract available


    October 2021
  72. XU S, Huang R, Sy LS, Glenn SC, et al
    COVID-19 Vaccination and Non-COVID-19 Mortality Risk - Seven Integrated Health Care Organizations, United States, December 14, 2020-July 31, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1520-1524.
    PubMed     Abstract available


  73. MUHOZA P, Danovaro-Holliday MC, Diallo MS, Murphy P, et al
    Routine Vaccination Coverage - Worldwide, 2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:1495-1500.
    PubMed     Abstract available


  74. OLSON SM, Newhams MM, Halasa NB, Price AM, et al
    Effectiveness of Pfizer-BioNTech mRNA Vaccination Against COVID-19 Hospitalization Among Persons Aged 12-18 Years - United States, June-September 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1483-1488.
    PubMed     Abstract available


  75. BLAU EF, Flinchum A, Gaub KL, Hartnett KP, et al
    Mycobacterium porcinum Skin and Soft Tissue Infections After Vaccinations - Indiana, Kentucky, and Ohio, September 2018-February 2019.
    MMWR Morb Mortal Wkly Rep. 2021;70:1472-1477.
    PubMed     Abstract available


  76. HILL HA, Yankey D, Elam-Evans LD, Singleton JA, et al
    Vaccination Coverage by Age 24 Months Among Children Born in 2017 and 2018 - National Immunization Survey-Child, United States, 2018-2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:1435-1440.
    PubMed     Abstract available


  77. VAN NAARDEN BRAUN K, Drexler M, Rozenfeld RA, Deener-Agus E, et al
    Multicomponent Strategies to Prevent SARS-CoV-2 Transmission - Nine Overnight Youth Summer Camps, United States, June-August 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1420-1424.
    PubMed     Abstract available


  78. HAUSE AM, Baggs J, Gee J, Marquez P, et al
    Safety Monitoring of an Additional Dose of COVID-19 Vaccine - United States, August 12-September 19, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1379-1384.
    PubMed     Abstract available


  79. MBAEYI C, Baig S, Khan Z, Young H, et al
    Progress Toward Poliomyelitis Eradication - Pakistan, January 2020-July 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1359-1364.
    PubMed     Abstract available


  80. RYERSON AB, Rice CE, Hung MC, Patel SA, et al
    Disparities in COVID-19 Vaccination Status, Intent, and Perceived Access for Noninstitutionalized Adults, by Disability Status - National Immunization Survey Adult COVID Module, United States, May 30-June 26, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1365-1371.
    PubMed     Abstract available


    September 2021
  81. DOOLING K, Gargano JW, Moulia D, Wallace M, et al
    Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged >/=16 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, September 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1344-1348.
    PubMed     Abstract available


  82. SELF WH, Tenforde MW, Rhoads JP, Gaglani M, et al
    Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1337-1343.
    PubMed     Abstract available


  83. HAGAN LM, McCormick DW, Lee C, Sleweon S, et al
    Outbreak of SARS-CoV-2 B.1.617.2 (Delta) Variant Infections Among Incarcerated Persons in a Federal Prison - Texas, July-August 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1349-1354.
    PubMed     Abstract available


  84. ROSENBERG ES, Holtgrave DR, Dorabawila V, Conroy M, et al
    New COVID-19 Cases and Hospitalizations Among Adults, by Vaccination Status - New York, May 3-July 25, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1306-1311.
    PubMed     Abstract available



  85. Correction and Republication: New COVID-19 Cases and Hospitalizations Among Adults, by Vaccination Status - New York, May 3-July 25, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1305.
    PubMed     Abstract available


  86. GRANNIS SJ, Rowley EA, Ong TC, Stenehjem E, et al
    Interim Estimates of COVID-19 Vaccine Effectiveness Against COVID-19-Associated Emergency Department or Urgent Care Clinic Encounters and Hospitalizations Among Adults During SARS-CoV-2 B.1.617.2 (Delta) Variant Predominance - Nine States, June-August
    MMWR Morb Mortal Wkly Rep. 2021;70:1291-1293.
    PubMed     Abstract available


  87. SCOBIE HM, Johnson AG, Suthar AB, Severson R, et al
    Monitoring Incidence of COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Status - 13 U.S. Jurisdictions, April 4-July 17, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1284-1290.
    PubMed     Abstract available


  88. BAJEMA KL, Dahl RM, Prill MM, Meites E, et al
    Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalization - Five Veterans Affairs Medical Centers, United States, February 1-August 6, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1294-1299.
    PubMed     Abstract available


  89. REBMANN T, Loux TM, Arnold LD, Charney R, et al
    SARS-CoV-2 Transmission to Masked and Unmasked Close Contacts of University Students with COVID-19 - St. Louis, Missouri, January-May 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1245-1248.
    PubMed     Abstract available


  90. SIEGEL DA, Reses HE, Cool AJ, Shapiro CN, et al
    Trends in COVID-19 Cases, Emergency Department Visits, and Hospital Admissions Among Children and Adolescents Aged 0-17 Years - United States, August 2020-August 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1249-1254.
    PubMed     Abstract available


  91. DELAHOY MJ, Ujamaa D, Whitaker M, O'Halloran A, et al
    Hospitalizations Associated with COVID-19 Among Children and Adolescents - COVID-NET, 14 States, March 1, 2020-August 14, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1255-1260.
    PubMed     Abstract available


  92. DOYLE K, Teran RA, Reefhuis J, Kerins JL, et al
    Multiple Variants of SARS-CoV-2 in a University Outbreak After Spring Break - Chicago, Illinois, March-May 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1195-1200.
    PubMed     Abstract available


  93. LAM-HINE T, McCurdy SA, Santora L, Duncan L, et al
    Outbreak Associated with SARS-CoV-2 B.1.617.2 (Delta) Variant in an Elementary School - Marin County, California, May-June 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1214-1219.
    PubMed     Abstract available


  94. PINGALI C, Yankey D, Elam-Evans LD, Markowitz LE, et al
    National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:1183-1190.
    PubMed     Abstract available


  95. MATTHIAS J, Patrick S, Wiringa A, Pullman A, et al
    Epidemiologically Linked COVID-19 Outbreaks at a Youth Camp and Men's Conference - Illinois, June-July 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1223-1227.
    PubMed     Abstract available


  96. MURTHY BP, Zell E, Saelee R, Murthy N, et al
    COVID-19 Vaccination Coverage Among Adolescents Aged 12-17 Years - United States, December 14, 2020-July 31, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1206-1213.
    PubMed     Abstract available


    August 2021
  97. BIGOUETTE JP, Wilkinson AL, Tallis G, Burns CC, et al
    Progress Toward Polio Eradication - Worldwide, January 2019-June 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1129-1135.
    PubMed     Abstract available


  98. GRIFFIN JB, Haddix M, Danza P, Fisher R, et al
    SARS-CoV-2 Infections and Hospitalizations Among Persons Aged >/=16 Years, by Vaccination Status - Los Angeles County, California, May 1-July 25, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1170-1176.
    PubMed     Abstract available


  99. TENFORDE MW, Self WH, Naioti EA, Ginde AA, et al
    Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults - United States, March-July 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1156-1162.
    PubMed     Abstract available


  100. FOWLKES A, Gaglani M, Groover K, Thiese MS, et al
    Effectiveness of COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Frontline Workers Before and During B.1.617.2 (Delta) Variant Predominance - Eight U.S. Locations, December 2020-August 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1167-1169.
    PubMed     Abstract available


  101. NANDURI S, Pilishvili T, Derado G, Soe MM, et al
    Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-Au
    MMWR Morb Mortal Wkly Rep. 2021;70:1163-1166.
    PubMed     Abstract available


  102. ROSENBERG ES, Holtgrave DR, Dorabawila V, Conroy M, et al
    New COVID-19 Cases and Hospitalizations Among Adults, by Vaccination Status - New York, May 3-July 25, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1150-1155.
    PubMed     Abstract available


  103. ROSENBLUM HG, Hadler SC, Moulia D, Shimabukuro TT, et al
    Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July
    MMWR Morb Mortal Wkly Rep. 2021;70:1094-1099.
    PubMed     Abstract available


  104. HERLIHY R, Bamberg W, Burakoff A, Alden N, et al
    Rapid Increase in Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - Mesa County, Colorado, April-June 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1084-1087.
    PubMed     Abstract available


  105. CAVANAUGH AM, Spicer KB, Thoroughman D, Glick C, et al
    Reduced Risk of Reinfection with SARS-CoV-2 After COVID-19 Vaccination - Kentucky, May-June 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1081-1083.
    PubMed     Abstract available


  106. MOLINE HL, Whitaker M, Deng L, Rhodes JC, et al
    Effectiveness of COVID-19 Vaccines in Preventing Hospitalization Among Adults Aged >/=65 Years - COVID-NET, 13 States, February-April 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1088-1093.
    PubMed     Abstract available


  107. YOON P, Hall J, Fuld J, Mattocks SL, et al
    Alternative Methods for Grouping Race and Ethnicity to Monitor COVID-19 Outcomes and Vaccination Coverage.
    MMWR Morb Mortal Wkly Rep. 2021;70:1075-1080.
    PubMed     Abstract available


  108. BROWN CM, Vostok J, Johnson H, Burns M, et al
    Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine Breakthrough Infections, Associated with Large Public Gatherings - Barnstable County, Massachusetts, July 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1059-1062.
    PubMed     Abstract available


  109. HAUSE AM, Gee J, Baggs J, Abara WE, et al
    COVID-19 Vaccine Safety in Adolescents Aged 12-17 Years - United States, December 14, 2020-July 16, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1053-1058.
    PubMed     Abstract available


    July 2021
  110. KHETSURIANI N, Mosina L, Van Damme P, Mozalevskis A, et al
    Progress Toward Hepatitis B Control - World Health Organization European Region, 2016-2019.
    MMWR Morb Mortal Wkly Rep. 2021;70:1029-1035.
    PubMed     Abstract available


  111. RUBIN D, Eisen M, Collins S, Pennington JW, et al
    SARS-CoV-2 Infection in Public School District Employees Following a District-Wide Vaccination Program - Philadelphia County, Pennsylvania, March 21-April 23, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1040-1043.
    PubMed     Abstract available


  112. LEE JT, Althomsons SP, Wu H, Budnitz DS, et al
    Disparities in COVID-19 Vaccination Coverage Among Health Care Personnel Working in Long-Term Care Facilities, by Job Category, National Healthcare Safety Network - United States, March 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1036-1039.
    PubMed     Abstract available


  113. CHRISTIE A, Brooks JT, Hicks LA, Sauber-Schatz EK, et al
    Guidance for Implementing COVID-19 Prevention Strategies in the Context of Varying Community Transmission Levels and Vaccination Coverage.
    MMWR Morb Mortal Wkly Rep. 2021;70:1044-1047.
    PubMed     Abstract available


  114. PINGALI C, Meghani M, Razzaghi H, Lamias MJ, et al
    COVID-19 Vaccination Coverage Among Insured Persons Aged >/=16 Years, by Race/Ethnicity and Other Selected Characteristics - Eight Integrated Health Care Organizations, United States, December 14, 2020-May 15, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:985-990.
    PubMed     Abstract available


  115. WONG CA, Dowler S, Moore AF, Sosne EF, et al
    COVID-19 Vaccine Administration, by Race and Ethnicity - North Carolina, December 14, 2020-April 6, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:991-996.
    PubMed     Abstract available


  116. SCHERER AM, Gedlinske AM, Parker AM, Gidengil CA, et al
    Acceptability of Adolescent COVID-19 Vaccination Among Adolescents and Parents of Adolescents - United States, April 15-23, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:997-1003.
    PubMed     Abstract available


  117. GARGANO JW, Wallace M, Hadler SC, Langley G, et al
    Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:977-982.
    PubMed     Abstract available


    June 2021
  118. BAACK BN, Abad N, Yankey D, Kahn KE, et al
    COVID-19 Vaccination Coverage and Intent Among Adults Aged 18-39 Years - United States, March-May 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:928-933.
    PubMed     Abstract available


  119. DIESEL J, Sterrett N, Dasgupta S, Kriss JL, et al
    COVID-19 Vaccination Coverage Among Adults - United States, December 14, 2020-May 22, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:922-927.
    PubMed     Abstract available


  120. RAZZAGHI H, Meghani M, Pingali C, Crane B, et al
    COVID-19 Vaccination Coverage Among Pregnant Women During Pregnancy - Eight Integrated Health Care Organizations, United States, December 14, 2020-May 8, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:895-899.
    PubMed     Abstract available



  121. QuickStats: Percentage* of Adults Aged >/=50 Years Who Ever Received a Shingles Vaccination,(dagger) by Race and Hispanic Origin( section sign) and Sex - National Health Interview Survey, United States, 2019( paragraph sign).
    MMWR Morb Mortal Wkly Rep. 2021;70:901.
    PubMed    


  122. CHRISTIE A, Henley SJ, Mattocks L, Fernando R, et al
    Decreases in COVID-19 Cases, Emergency Department Visits, Hospital Admissions, and Deaths Among Older Adults Following the Introduction of COVID-19 Vaccine - United States, September 6, 2020-May 1, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:858-864.
    PubMed     Abstract available


  123. PATEL MURTHY B, Zell E, Kirtland K, Jones-Jack N, et al
    Impact of the COVID-19 Pandemic on Administration of Selected Routine Childhood and Adolescent Vaccinations - 10 U.S. Jurisdictions, March-September 2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:840-845.
    PubMed     Abstract available


  124. O'CONNOR P, Yankovic D, Zimmerman L, Ben Mamou M, et al
    Progress Toward Rubella Elimination - World Health Organization European Region, 2005-2019.
    MMWR Morb Mortal Wkly Rep. 2021;70:833-839.
    PubMed     Abstract available


  125. BARRY V, Dasgupta S, Weller DL, Kriss JL, et al
    Patterns in COVID-19 Vaccination Coverage, by Social Vulnerability and Urbanicity - United States, December 14, 2020-May 1, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:818-824.
    PubMed     Abstract available


    May 2021

  126. COVID-19 Vaccine Breakthrough Infections Reported to CDC - United States, January 1-April 30, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:792-793.
    PubMed     Abstract available



  127. QuickStats: Percentage* of Adults Aged 18-26 Years Who Ever Received a Human Papillomavirus Vaccine,(dagger) by Race and Hispanic Origin( section sign) and Sex - National Health Interview Survey, United States, 2019( paragraph sign).
    MMWR Morb Mortal Wkly Rep. 2021;70:797.
    PubMed    


  128. WALLACE M, Woodworth KR, Gargano JW, Scobie HM, et al
    The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12-15 Years - United States, May 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:749-752.
    PubMed     Abstract available


  129. MURTHY BP, Sterrett N, Weller D, Zell E, et al
    Disparities in COVID-19 Vaccination Coverage Between Urban and Rural Counties - United States, December 14, 2020-April 10, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:759-764.
    PubMed     Abstract available


  130. PILISHVILI T, Fleming-Dutra KE, Farrar JL, Gierke R, et al
    Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel - 33 U.S. Sites, January-March 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:753-758.
    PubMed     Abstract available


  131. BORCHERING RK, Viboud C, Howerton E, Smith CP, et al
    Modeling of Future COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Rates and Nonpharmaceutical Intervention Scenarios - United States, April-September 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:719-724.
    PubMed     Abstract available


  132. WHITEMAN A, Wang A, McCain K, Gunnels B, et al
    Demographic and Social Factors Associated with COVID-19 Vaccination Initiation Among Adults Aged >/=65 Years - United States, December 14, 2020-April 10, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:725-730.
    PubMed     Abstract available


  133. SHAY DK, Gee J, Su JR, Myers TR, et al
    Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine - United States, March-April 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:680-684.
    PubMed     Abstract available


  134. TENFORDE MW, Olson SM, Self WH, Talbot HK, et al
    Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged >/=65 Years - United States, January-March 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:674-679.
    PubMed     Abstract available


  135. HAUSE AM, Gee J, Johnson T, Jazwa A, et al
    Anxiety-Related Adverse Event Clusters After Janssen COVID-19 Vaccination - Five U.S. Mass Vaccination Sites, April 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:685-688.
    PubMed     Abstract available


    April 2021
  136. MACNEIL JR, Su JR, Broder KR, Guh AY, et al
    Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients - United States, April 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:651-656.
    PubMed     Abstract available


  137. CAVANAUGH AM, Fortier S, Lewis P, Arora V, et al
    COVID-19 Outbreak Associated with a SARS-CoV-2 R.1 Lineage Variant in a Skilled Nursing Facility After Vaccination Program - Kentucky, March 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:639-643.
    PubMed     Abstract available


  138. TERAN RA, Walblay KA, Shane EL, Xydis S, et al
    Postvaccination SARS-CoV-2 Infections Among Skilled Nursing Facility Residents and Staff Members - Chicago, Illinois, December 2020-March 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:632-638.
    PubMed     Abstract available


  139. DUNNE EM, Morgan E, Wells-Moore B, Pierson S, et al
    COVID-19 Outbreaks in Correctional Facilities with Work-Release Programs - Idaho, July-November 2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:589-594.
    PubMed     Abstract available



  140. QuickStats: Age-Adjusted Percentage* of Adults Aged >/=18 Years Who Had an Influenza Vaccination in the Past 12 Months,(dagger) by Sex and Race/Ethnicity( section sign) - National Health Interview Survey, United States, 2019( paragraph sign).
    MMWR Morb Mortal Wkly Rep. 2021;70:536.
    PubMed    


  141. THOMPSON MG, Burgess JL, Naleway AL, Tyner HL, et al
    Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers - Eight U.S. Locations, December 2020-Ma
    MMWR Morb Mortal Wkly Rep. 2021;70:495-500.
    PubMed     Abstract available


  142. STERN MF, Piasecki AM, Strick LB, Rajeshwar P, et al
    Willingness to Receive a COVID-19 Vaccination Among Incarcerated or Detained Persons in Correctional and Detention Facilities - Four States, September-December 2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:473-477.
    PubMed     Abstract available


    March 2021
  143. ROSENBLUM HG, Lewis RM, Gargano JW, Querec TD, et al
    Declines in Prevalence of Human Papillomavirus Vaccine-Type Infection Among Females after Introduction of Vaccine - United States, 2003-2018.
    MMWR Morb Mortal Wkly Rep. 2021;70:415-420.
    PubMed     Abstract available


  144. HUGHES MM, Wang A, Grossman MK, Pun E, et al
    County-Level COVID-19 Vaccination Coverage and Social Vulnerability - United States, December 14, 2020-March 1, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:431-436.
    PubMed     Abstract available


  145. KRISS JL, Reynolds LE, Wang A, Stokley S, et al
    COVID-19 Vaccine Second-Dose Completion and Interval Between First and Second Doses Among Vaccinated Persons - United States, December 14, 2020-February 14, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:389-395.
    PubMed     Abstract available


  146. BRITTON A, Jacobs Slifka KM, Edens C, Nanduri SA, et al
    Effectiveness of the Pfizer-BioNTech COVID-19 Vaccine Among Residents of Two Skilled Nursing Facilities Experiencing COVID-19 Outbreaks - Connecticut, December 2020-February 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:396-401.
    PubMed     Abstract available


  147. RINOTT E, Youngster I, Lewis YE
    Reduction in COVID-19 Patients Requiring Mechanical Ventilation Following Implementation of a National COVID-19 Vaccination Program - Israel, December 2020-February 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:326-328.
    PubMed    


  148. OLIVER SE, Gargano JW, Scobie H, Wallace M, et al
    The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Janssen COVID-19 Vaccine - United States, February 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:329-332.
    PubMed    


    February 2021
  149. GEE J, Marquez P, Su J, Calvert GM, et al
    First Month of COVID-19 Vaccine Safety Monitoring - United States, December 14, 2020-January 13, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:283-288.
    PubMed     Abstract available


  150. HONG K, Zhou F, Tsai Y, Jatlaoui TC, et al
    Decline in Receipt of Vaccines by Medicare Beneficiaries During the COVID-19 Pandemic - United States, 2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:245-249.
    PubMed     Abstract available


  151. NGUYEN KH, Srivastav A, Razzaghi H, Williams W, et al
    COVID-19 Vaccination Intent, Perceptions, and Reasons for Not Vaccinating Among Groups Prioritized for Early Vaccination - United States, September and December 2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:217-222.
    PubMed     Abstract available


  152. PAINTER EM, Ussery EN, Patel A, Hughes MM, et al
    Demographic Characteristics of Persons Vaccinated During the First Month of the COVID-19 Vaccination Program - United States, December 14, 2020-January 14, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:174-177.
    PubMed     Abstract available


  153. GHARPURE R, Guo A, Bishnoi CK, Patel U, et al
    Early COVID-19 First-Dose Vaccination Coverage Among Residents and Staff Members of Skilled Nursing Facilities Participating in the Pharmacy Partnership for Long-Term Care Program - United States, December 2020-January 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:178-182.
    PubMed     Abstract available


    January 2021

  154. Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Moderna COVID-19 Vaccine - United States, December 21, 2020-January 10, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:125-129.
    PubMed     Abstract available


  155. SEITHER R, McGill MT, Kriss JL, Mellerson JL, et al
    Vaccination Coverage with Selected Vaccines and Exemption Rates Among Children in Kindergarten - United States, 2019-20 School Year.
    MMWR Morb Mortal Wkly Rep. 2021;70:75-82.
    PubMed     Abstract available



  156. Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine - United States, December 14-23, 2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:46-51.
    PubMed     Abstract available


  157. OLIVER SE, Gargano JW, Marin M, Wallace M, et al
    The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Moderna COVID-19 Vaccine - United States, December 2020.
    MMWR Morb Mortal Wkly Rep. 2021;69:1653-1656.
    PubMed     Abstract available


  158. DOOLING K, Marin M, Wallace M, McClung N, et al
    The Advisory Committee on Immunization Practices' Updated Interim Recommendation for Allocation of COVID-19 Vaccine - United States, December 2020.
    MMWR Morb Mortal Wkly Rep. 2021;69:1657-1660.
    PubMed     Abstract available


  159. ZOMAHOUN DJ, Burman AL, Snider CJ, Chauvin C, et al
    Impact of COVID-19 Pandemic on Global Poliovirus Surveillance.
    MMWR Morb Mortal Wkly Rep. 2021;69:1648-1652.
    PubMed     Abstract available


    December 2020
  160. OLIVER SE, Gargano JW, Marin M, Wallace M, et al
    The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine - United States, December 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1922-1924.
    PubMed     Abstract available


  161. DOOLING K, McClung N, Chamberland M, Marin M, et al
    The Advisory Committee on Immunization Practices' Interim Recommendation for Allocating Initial Supplies of COVID-19 Vaccine - United States, 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1857-1859.
    PubMed     Abstract available


    November 2020
  162. MCCLUNG N, Chamberland M, Kinlaw K, Bowen Matthew D, et al
    The Advisory Committee on Immunization Practices' Ethical Principles for Allocating Initial Supplies of COVID-19 Vaccine - United States, 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1782-1786.
    PubMed     Abstract available


  163. HSU CH, Rehman MS, Bullard K, Jorba J, et al
    Progress Toward Poliomyelitis Eradication - Pakistan, January 2019-September 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1748-1752.
    PubMed     Abstract available


  164. PATEL MK, Goodson JL, Alexander JP Jr, Kretsinger K, et al
    Progress Toward Regional Measles Elimination - Worldwide, 2000-2019.
    MMWR Morb Mortal Wkly Rep. 2020;69:1700-1705.
    PubMed     Abstract available


    October 2020
  165. HILL HA, Yankey D, Elam-Evans LD, Singleton JA, et al
    Vaccination Coverage by Age 24 Months Among Children Born in 2016 and 2017 - National Immunization Survey-Child, United States, 2017-2019.
    MMWR Morb Mortal Wkly Rep. 2020;69:1505-1511.
    PubMed     Abstract available


  166. MARTINEZ M, Akbar IE, Wadood MZ, Shukla H, et al
    Progress Toward Poliomyelitis Eradication - Afghanistan, January 2019-July 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1464-1468.
    PubMed     Abstract available


  167. RAZZAGHI H, Kahn KE, Black CL, Lindley MC, et al
    Influenza and Tdap Vaccination Coverage Among Pregnant Women - United States, April 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1391-1397.
    PubMed     Abstract available


    September 2020
  168. MOFFETT DB, Llewellyn A, Singh H, Saxentoff E, et al
    Progress Toward Poliovirus Containment Implementation - Worldwide, 2019-2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1330-1333.
    PubMed     Abstract available


    June 2020
  169. VANCE J, Gonzalez F, Estrada E, Ocaranza HI, et al
    Notes from the Field: Measles Outbreak on an Army Post and a Neighboring Community - El Paso, Texas, July-September 2019.
    MMWR Morb Mortal Wkly Rep. 2020;69:722-723.
    PubMed    


    May 2020
  170. HOFMEISTER MG, Foster MA, Montgomery MP, Gupta N, et al
    Notes from the Field: Assessing the Role of Food Handlers in Hepatitis A Virus Transmission - Multiple States, 2016-2019.
    MMWR Morb Mortal Wkly Rep. 2020;69:636-637.
    PubMed    


  171. STEIN-ZAMIR C, Abramson N, Shoob H
    Notes from the Field: Large Measles Outbreak in Orthodox Jewish Communities - Jerusalem District, Israel, 2018-2019.
    MMWR Morb Mortal Wkly Rep. 2020;69:562-563.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: